Evidence analysisOctober 29, 2026Health & Science
First public health emergency preparedness assessments across Europe show both commitment and recurring challenges

FreedomWitness Evidence Engine: This is an AI-assisted original analysis built from the linked source and available public source context. It separates evidence from interpretation and may challenge conventional framing only where the evidence supports it. It is not a copied article.
What is established
The European Centre for Disease Prevention and Control (ECDC), in collaboration with the European Commission, the World Health Organization (WHO) Regional Office for Europe, and other partners, conducted for the first time a comprehensive Public Health Emergency Preparedness Assessment (PHEPA) cycle across all EU/EEA countries. This initial cycle, spanning from 2024 to 2026, evaluated national capacities to prevent, prepare for, and respond to public health threats and crises.
The assessments addressed several key components, including surveillance systems, laboratory capacity, health emergency management, risk communication, and intersectoral coordination mechanisms. The exercise revealed that many countries, especially since the COVID-19 pandemic, have strengthened governance structures and improved laboratory and surveillance capabilities. Core capacities such as laboratory networks, disease surveillance, and emergency health management are generally strong across the EU/EEA region.
The PHEPAs are designed to recur every three years, forming part of a continuing cycle of reporting and evaluation, with future rounds planned to focus further on the implementation of action plans derived from initial recommendations.
What the source claims
According to the ECDC news release dated October 29, 2026, the first PHEPA cycle has demonstrated a robust collective commitment by EU/EEA countries to emergency preparedness. This commitment is evidenced by various improvements made post-COVID-19 in foundational systems.
Nevertheless, several recurring challenges persist. These challenges include:
- Preparedness and response plans that exist but are not consistently implemented in practice;
- Insufficient staffing resources to maintain and operate emergency readiness;
- Limited interoperability of data sharing systems, hindering timely access to and integration of critical information;
- Difficulties in transforming surveillance and other data into actionable policy decisions;
- A need for enhanced formalized cross-sector coordination and more frequent testing of preparedness plans through exercises.
As a response, ECDC recommends strengthening advanced multi-sector planning, formalizing intersectoral coordination, and routinely conducting preparedness exercises. The completion of this first assessment cycle marks the transition toward practical follow-up actions informed by the findings. The results will guide targeted country support to enable implementation of recommendations and shape the focus of the second assessment cycle (2027–2029).
What may be missing from the usual framing
While ECDC’s report highlights important progress and specific areas for improvement, the source does not deeply explore systemic factors influencing preparedness beyond operational and technical capacity. There is limited examination of structural or political determinants that may affect implementation, such as national budget priorities, health system governance complexities, or the influence of differing national public health legislative frameworks.
The assessment also omits detailed discussion of the potential challenges posed by emerging health threats beyond the recent COVID-19 experience, such as antimicrobial resistance, climate-driven vector-borne diseases, or chronic disease exacerbations during emergencies. Additionally, how socioeconomic disparities within countries might affect preparedness and response quality is not addressed.
The source presents ECDC’s perspective as the organizer and coordinator of the assessments, potentially reflecting institutional emphasis on technical capacities and interagency collaboration, but not extensively discussing civil society or community-level readiness.
Competing evidence or uncertainty
Currently, the evidence is primarily based on ECDC’s official assessment. Independent or external evaluations of the PHEPA process or of individual country preparedness are limited in publicly available sources as of this date. Therefore, corroborating or contrasting perspectives on the degree and nature of preparedness across Europe are insufficiently documented.
Moreover, the reported improvements and remaining challenges are derived from self-assessments and ECDC’s analysis, which may contain inherent limitations such as national reporting biases, variable transparency, or differing interpretation of assessment criteria.
The precise impact of the recommended actions on future emergency outcomes remains uncertain until further implementation and subsequent reassessment cycles occur. Similarly, the complex interplay of political will, resource allocation, and real-world emergency events creates uncertainty regarding actual preparedness resilience beyond documented capacity.
Why it matters
The capacity of EU/EEA countries to detect, prepare for, and respond promptly to public health emergencies is critical not only for protecting health and lives but also for safeguarding social and economic stability. The COVID-19 pandemic underscored the widespread effects of insufficient preparedness, prompting renewed focus on strengthening public health systems.
Having robust assessments like the PHEPA cycle provides an evidence-based framework for identifying strengths and weaknesses within and across countries, facilitating targeted investments and policy development. These efforts can help reduce response delays, improve risk communication, and optimize resource use during crises.
Persistent challenges in plan implementation, staffing, data interoperability, and policy translation may weaken the overall resilience of health emergency systems. Addressing these challenges systematically supports better outcomes in future public health events, including outbreaks of infectious diseases or other health threats.
What to verify next
- Independent evaluations or audits of the PHEPA findings and their implementation status in diverse EU/EEA countries.
- Data from civil society, healthcare providers, and subnational authorities that may provide ground-level perspectives on preparedness and response capabilities.
- Information on national budget allocations and political commitments related to health emergency preparedness post-2026.
- Research on how interoperability challenges and data sharing limitations are being practically addressed, especially involving newer digital tools or cross-border data frameworks.
- Updates from the second PHEPA cycle (2027–2029) when available, including assessments of progress on recommendations and national action plans.
- Studies investigating the integration of socio-economic and equity considerations into preparedness planning within the EU/EEA.
Readers interested in detailed information and official documentation about the PHEPA assessments should consult the original ECDC publication.
Source & verification
Primary source: News content · October 29, 2026
FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.
Continue reading

EudraGMDP database
What is established The EudraGMDP database is an established European Union (EU) information system managed by the European Medicines Agency (EMA). It serves as…

Antimicrobial resistance in the EU/EEA (EARS-Net) – Annual Epidemiological Report for 2025
Evidence Dossier: Antimicrobial Resistance Trends in the EU/EEA 2025 Antimicrobial Resistance Trends in the EU/EEA: Evidence from the 2025 EARS-Net Report What is established…

Rapid risk assessment – Carbapenem-resistant Enterobacterales, fourth update
Evidence Dossier: Carbapenem-resistant Enterobacterales (CRE) in the EU/EEA – Latest Scientific Assessment What is established Carbapenem-resistant Enterobacterales (CRE), which include bacteria such as Klebsiella…